Top Markets
#1 Pons Pons +10.72%
#2 StonkBroker StonkBroker +7.70%
#3 龙虾 (Lobster) 龙虾 (Lobster) +7.11%
#4 Siacoin Siacoin +6.63%
#5 Story Story +5.66%
#6 Cash Cat Cash Cat +5.40%
#7 Unit Pump Unit Pump +4.76%
#8 Pump.fun Pump.fun +4.76%
#9 Status Status +4.75%
#10 Seeker Seeker +4.04%
Coin of the day
Pons Pons
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Carlsmed, Inc. Carlsmed, Inc.

Carlsmed, Inc.

CARL
Hisse Senetlerindeki Sıralama #14037
Carlsmed, Inc., a commercial-stage medical technology company, designs,... Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Hisse Fiyatı
$16.23
Son senkronizasyon: 2026-08-31
Piyasa Değeri
$441.21M
Değişim (1 gün)
-3.85%
Değişim (1 yıl)
22.03%
Ülke
US
Ticaret Carlsmed, Inc. (CARL)

Kategori

Healthcare
Carlsmed, Inc. (CARL) için temettü verimi geçmişi
Carlsmed, Inc. (hisse sembolü: CARL) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Carlsmed, Inc. (CARL) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)
Şirket Temettü Verimi Ülke
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US